99 related articles for article (PubMed ID: 7912526)
21. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
22. Biweekly paclitaxel (Taxol) and cisplatin in breast and ovarian cancer.
Gelmon KA
Semin Oncol; 1994 Oct; 21(5 Suppl 8):24-8. PubMed ID: 7939758
[TBL] [Abstract][Full Text] [Related]
23. Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute.
Christian MC; Pluda JM; Ho PT; Arbuck SG; Murgo AJ; Sausville EA
Semin Oncol; 1997 Apr; 24(2):219-40. PubMed ID: 9129691
[TBL] [Abstract][Full Text] [Related]
24. The pharmacoeconomics of cancer therapies.
Bishop JF; Macarounas-Kirchman K
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-106-S19-111. PubMed ID: 9427279
[TBL] [Abstract][Full Text] [Related]
25. Paclitaxel and carboplatin for advanced breast cancer.
Perez EA; Hartmann LC
Semin Oncol; 1996 Oct; 23(5 Suppl 11):41-5. PubMed ID: 8893899
[TBL] [Abstract][Full Text] [Related]
26. The taxol supply crisis. New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agents.
Cragg GM; Schepartz SA; Suffness M; Grever MR
J Nat Prod; 1993 Oct; 56(10):1657-68. PubMed ID: 7903979
[TBL] [Abstract][Full Text] [Related]
27. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
28. Role of paclitaxel in the treatment of breast cancer: the American Cooperative Group Experience.
Sledge GW
Semin Oncol; 1996 Feb; 23(1 Suppl 1):10-2. PubMed ID: 8629029
[TBL] [Abstract][Full Text] [Related]
29. Cancer chemotherapy, biodiversity, public and private property: the case of the anti-cancer drug taxol.
Walsh V; Goodman J
Soc Sci Med; 1999 Nov; 49(9):1215-25. PubMed ID: 10501642
[TBL] [Abstract][Full Text] [Related]
30. Single-agent paclitaxel for the treatment of breast cancer: an overview.
Hortobagyi GN; Holmes FA
Semin Oncol; 1996 Feb; 23(1 Suppl 1):4-9. PubMed ID: 8629036
[TBL] [Abstract][Full Text] [Related]
31. Biotechnological production of taxol and related taxoids: current state and prospects.
Expósito O; Bonfill M; Moyano E; Onrubia M; Mirjalili MH; Cusidó RM; Palazón J
Anticancer Agents Med Chem; 2009 Jan; 9(1):109-21. PubMed ID: 19149486
[TBL] [Abstract][Full Text] [Related]
32. A phase II study of repetitive cycles of dose-intense carboplatin plus paclitaxel chemotherapy and peripheral blood stem cells in metastatic breast cancer.
Ford C; Spitzer G; Reilly W; Adkins D
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-81-S17-86. PubMed ID: 9374101
[TBL] [Abstract][Full Text] [Related]
33. Dose-escalation study of weekly 1-hour paclitaxel administration in patients with refractory cancer.
Chang AY; Boros L; Asbury R; Hui L; Rubins J
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-69-S17-71. PubMed ID: 9374098
[TBL] [Abstract][Full Text] [Related]
34. From taxol to Taxol: the changing identities and ownership of an anti-cancer drug.
Walsh V; Goodman J
Med Anthropol; 2002; 21(3-4):307-36. PubMed ID: 12458837
[TBL] [Abstract][Full Text] [Related]
35. Use of paclitaxel (Taxol) in squamous cell carcinoma of the head and neck.
Forastiere AA
Semin Oncol; 1993 Aug; 20(4 Suppl 3):56-60. PubMed ID: 8102018
[TBL] [Abstract][Full Text] [Related]
36. Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer.
Lück HJ; Thomssen C; du Bois A; Untch M; Lisboa B; Köhler G; Diergarten K
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-35-S17-39. PubMed ID: 9374090
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacological action of paclitaxel].
Potemski P; Płuzańska A
Pol Merkur Lekarski; 1999 Jan; 6(31):27-9. PubMed ID: 10344150
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel with carboplatin for the treatment of ovarian cancer.
Neijt JP; Lund B
Semin Oncol; 1996 Dec; 23(6 Suppl 15):2-4. PubMed ID: 8996588
[TBL] [Abstract][Full Text] [Related]
39. Effects of inoculum size and age on biomass growth and paclitaxel production of elicitor-treated Taxus yunnanensis cell cultures.
Zhang CH; Wu JY; He GY
Appl Microbiol Biotechnol; 2002 Dec; 60(4):396-402. PubMed ID: 12466878
[TBL] [Abstract][Full Text] [Related]
40. Clinical Trials: A Congressional Focus of Need.
Coltman CA
Oncologist; 1997; 2(4):VII-VIII. PubMed ID: 10388059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
